T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024
T2 Biosystems (NASDAQ:TTOO), a company specializing in rapid detection of sepsis-causing pathogens and antibiotic resistance genes, has announced it will release its third quarter 2024 financial results after market close on Thursday, November 14, 2024. The company will host a conference call at 4:30 p.m. Eastern Time to discuss the results and provide business updates. Investors can access the call via webcast at www.t2biosystems.com or by dialing 877-545-0320 (US/Canada) or 973-528-0002 (International) using passcode 903508.
T2 Biosystems (NASDAQ:TTOO), un'azienda specializzata nella scoperta rapida di patogeni responsabili della sepsi e di geni di resistenza agli antibiotici, ha annunciato che pubblicherà i suoi risultati finanziari del terzo trimestre 2024 dopo la chiusura del mercato giovedì 14 novembre 2024. L'azienda organizzerà una conferenza telefonica alle 16:30, ora orientale, per discutere i risultati e fornire aggiornamenti aziendali. Gli investitori possono accedere alla chiamata tramite webcast su www.t2biosystems.com o componendo il numero 877-545-0320 (US/Canada) o 973-528-0002 (Internazionale) utilizzando il codice di accesso 903508.
T2 Biosystems (NASDAQ:TTOO), una empresa especializada en la detección rápida de patógenos que causan sepsis y genes de resistencia a los antibióticos, ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 después del cierre del mercado el jueves 14 de noviembre de 2024. La empresa llevará a cabo una llamada de conferencia a las 4:30 p.m. Hora del Este para discutir los resultados y proporcionar actualizaciones comerciales. Los inversores pueden acceder a la llamada a través de webcast en www.t2biosystems.com o marcando el 877-545-0320 (EE.UU./Canadá) o el 973-528-0002 (Internacional) utilizando el código de acceso 903508.
T2 바이오시스템즈 (NASDAQ:TTOO)는 패혈증을 유발하는 병원체 및 항생제 내성 유전자의 신속한 탐지를 전문으로 하는 회사로, 2024년 11월 14일 목요일 시장 마감 후에 2024년 3분기 재무 결과를 발표한다고 발표했습니다. 회사는 동부 표준시 기준 오후 4시 30분에 결과와 비즈니스 업데이트를 논의하기 위한 컨퍼런스 콜을 개최할 예정입니다. 투자자는 www.t2biosystems.com을 통해 웹캐스트로 또는 877-545-0320 (미국/캐나다) 또는 973-528-0002 (국제)로 전화하여 접속할 수 있으며, 비밀번호는 903508입니다.
T2 Biosystems (NASDAQ:TTOO), une entreprise spécialisée dans la détection rapide des pathogènes responsables de la septicémie et des gènes de résistance aux antibiotiques, a annoncé qu'elle publiera ses résultats financiers pour le troisième trimestre 2024 après la fermeture du marché le jeudi 14 novembre 2024. L'entreprise organisera une conférence téléphonique à 16h30, heure de l'Est, pour discuter des résultats et fournir des mises à jour sur l'entreprise. Les investisseurs peuvent accéder à l'appel via webcast sur www.t2biosystems.com ou en composant le 877-545-0320 (États-Unis/Canada) ou le 973-528-0002 (International) en utilisant le code d'accès 903508.
T2 Biosystems (NASDAQ:TTOO), ein Unternehmen, das sich auf die schnelle Erkennung von sepsisverursachenden Krankheitserregern und Antibiotika-Resistenzgenen spezialisiert hat, hat angekündigt, dass es seine Finanzergebnisse für das dritte Quartal 2024 nach Marktende am Donnerstag, den 14. November 2024, veröffentlichen wird. Das Unternehmen wird um 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen und Geschäftsinformationen bereitzustellen. Investoren können über die Webseite www.t2biosystems.com auf den Anruf zugreifen oder die Nummer 877-545-0320 (US/Kanada) oder 973-528-0002 (international) wählen, unter Verwendung des Zugangscodes 903508.
- None.
- None.
LEXINGTON, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the third quarter 2024 and business updates after market close on Thursday, November 14, 2024.
Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.t2biosystems.com, on the Investors page in the Events & Presentations section. To listen to the conference call, please dial 877-545-0320 (US/Canada) or 973-528-0002 (International), passcode 903508, approximately ten to five minutes prior to the start time.
About T2 Biosystems
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology and include the T2Dx® Instrument, the T2Bacteria® Panel, the T2Candida® Panel, the T2Resistance® Panel, and the T2Biothreat™ Panel. T2 Biosystems has an active pipeline of future products, including the U.S. T2Resistance Panel, the T2Lyme™ Panel, and the expended T2Candida Panel to add the detection of Candida auris. For more information, please visit www.t2biosystems.com.
Investor Contact:
Philip Trip Taylor, Gilmartin Group
ir@T2Biosystems.com
415-937-5406
FAQ
When will T2 Biosystems (TTOO) report Q3 2024 earnings?
How can investors join T2 Biosystems (TTOO) Q3 2024 earnings call?
What is the conference call passcode for T2 Biosystems (TTOO) Q3 2024 earnings?
